跳至主要内容
临床试验/jRCTs042180027
jRCTs042180027已完成不适用

Impact of Genetic Testing on Low-density Lipoprotein Cholesterol in Patients with Familial Hypercholesterolemia (GenTLe-FH study)

未提供0 个研究点目标入组 100 人开始时间: 2018年4月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Parallel Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
15age old over 至 No limit(—)
性别
All

入选标准

  • •We include the patients with all the following criteria:
  • •Age equal or more than 15 years
  • •Diagnosed with familial hypercholesterolemia per the criteria of the Japan
  • •Atherosclerosis Society
  • •Patients who have never got genetic tests, or have not yet returned genetic
  • •results regarding familial hypercholesterolemia
  • •Patients who can provide written informed consent

排除标准

  • •We exclude patients with either of the following criteria:
  • •Liver dysfunction (AST or ALT > 3 times the UNL)
  • •Renal dysfunction (Cr equal or more than 2.0 mg/dL)
  • •Immunosuppression
  • •Active cancer
  • •Previous history of coronary heart disease:
  • •i) Myocardial infarction
  • •ii) History of percutaneous coronary intervention or coronary artery bypass graft
  • •iii) Coronary stenosis (equal or more than 75%) previously detected by coronary angiography
  • •Female with pregnancy or expected
  • •Patients whose doctors in charge consider him/her inappropriate to participate

结局指标

主要结局

-

The plasma LDL cholesterol levels at 24 weeks

次要结局

  • Patients Satisfaction Questionnaire Short Form (PSQ-18) scores(24 and 48 weeks)

研究者

发起方
未提供

相似试验